Immunotherapy in AML: a brief review on emerging strategies.

Moeinafshar, A; Hemmati, S; Rezaei, N

Moeinafshar, A; Hemmati, S; Rezaei, N.

Afiliación

Moeinafshar A; Cancer Immunology Project Interest Group (CIP), Universal Scientific Education and Research Network (USERN), Tehran, Iran.
Hemmati S; School of Medicine, Tehran University of Medical Sciences, Tehran, Iran.
Rezaei N; Cancer Immunology Project Interest Group (CIP), Universal Scientific Education and Research Network (USERN), Tehran, Iran.

Clin Transl Oncol ; 23(12): 2431-2447, 2021 Dec.

Article en En | MEDLINE | ID: mdl-34160771

Asunto(s)

Inmunoterapia/métodos; Leucemia Mieloide Aguda/terapia; Humanos; Pronóstico

Palabras clave

Acute myeloid leukemia; Checkpoint inhibitor; Cytokine; Engineered T cells; Immunotherapy; Stem cell transplantation; Vaccine

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Leucemia Mieloide Aguda / Inmunoterapia Tipo de estudio: Prognostic_studies Idioma: En Revista: Clin Transl Oncol Año: 2021 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google